Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
11.54
+0.20 (1.76%)
Aug 18, 2026, 10:49 AM EDT - Market open
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $825.56 million as of August 18, 2026. Its market cap has increased by 1,128.82% in one year.
Market Cap
825.56M
Enterprise Value
594.46M
1-Year Change
1,128.82%
Ranking
Category
Stock Price
$11.54
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $825.56M, an increase of 1,155.73%. That is a compound annual growth rate of 72.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 784.79M | 184.76% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 862.29M |
| Adlai Nortye | 859.07M |
| Faeth Therapeutics | 846.79M |
| Pharming Group | 839.53M |
| Oculis Holding AG | 811.16M |
| 4D Molecular Therapeutics | 803.53M |
| Aura Biosciences | 796.45M |
| Rigel Pharmaceuticals | 792.96M |